ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,061Medicare Part D Prescriptions Filled, Including Refills

Rank: 122 out of 917

$531K Total Retail Price of All Prescriptions

Rank: 103 out of 917

446 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 446 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

18% of this provider’s 446 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,699 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
OMEPRAZOLE 323 274 1 4
AMLODIPINE BESYLATE 312 280 2 5
HYDROCODONE-ACETAMINOPHEN 276 225 S3 3 6
POTASSIUM CHLORIDE 274 269 4 16
FUROSEMIDE 270 263 5 7
LOVASTATIN 263 225 6 19
LISINOPRIL 257 226 7 1
LOSARTAN POTASSIUM 253 227 8 13
LEVOTHYROXINE SODIUM 245 201 9 3
ATENOLOL 240 197 10 12
PRAVASTATIN SODIUM 204 180 11 20
METOPROLOL SUCCINATE 203 186 12 18
METFORMIN HCL 177 165 13 8
GABAPENTIN 157 117 14 17
SIMVASTATIN 140 113 15 2
TRAMADOL HCL 135 115 16 28
ACETAMINOPHEN-CODEINE 121 113 S3 17 109
TAMSULOSIN HCL 120 116 18 25
ENALAPRIL MALEATE 107 102 19 79
ATORVASTATIN CALCIUM 105 83 20 14
HYDROCHLOROTHIAZIDE 98 96 21 9
ALLOPURINOL 93 85 22 31
METOPROLOL TARTRATE 92 74 23 11
PROAIR HFA 84 53 24 35
LANTUS 84 64 24 37
DIGOXIN 83 83 26 41
ISOSORBIDE MONONITRATE ER 80 74 27 70
OXYCODONE-ACETAMINOPHEN 77 51 S2 28 46
LABETALOL HCL 74 52 29 188
GLIPIZIDE 71 63 30 40
METHOCARBAMOL 71 64 R 30 87
RANITIDINE HCL 71 71 30 29
CRESTOR 70 70 33 30
CITALOPRAM HBR 69 64 34 15
TRAZODONE HCL 69 65 34 22
INSULIN SYRINGE 68 50 36 83
ALENDRONATE SODIUM 68 65 36 23
WARFARIN SODIUM 64 61 38 10
VENLAFAXINE HCL 60 52 39 179
SPIRONOLACTONE 58 58 40 55
POLYETHYLENE GLYCOL 3350 57 33 41 66
FENTANYL 55 54 S2 42 58
HUMALOG 52 37 43 151
PROPRANOLOL HCL 50 42 44 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.